We are live on ! Find out more
PM

Prosight Management Portfolio holdings

AUM $580M
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+39.55%
5 Year Est. Return
-6.93%
10 Year Est. Return
–
AUM
$210M
AUM Growth
-$22.7M
Cap. Flow
+$4.13M
Cap. Flow %
1.97%
Top 10 Hldgs %
48.59%
Holding
65
New
13
Increased
16
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
CUE icon
Cue Biopharma
CUE
+$7.68M
2
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$7.29M
3
BAX icon
Baxter International
BAX
+$6.69M
4
PRTA icon
Prothena Corp
PRTA
+$6.56M
5
MTCR
Metacrine, Inc. Common Stock
MTCR
+$5.31M

Top Sells

Rank Stock Value
1
KURA icon
Kura Oncology
KURA
+$12.8M
2
ARWR icon
Arrowhead Research
ARWR
+$4.93M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$4.28M
4
ALDX icon
Aldeyra Therapeutics
ALDX
+$3.41M
5
VCEL icon
Vericel Corp
VCEL
+$2.9M

Sector Composition

Rank Sector Weight
1 Healthcare 92.06%
2 Technology 4.31%
3 Miscellaneous 3.63%
4 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOLS icon
51
CALL
Evolus
EOLS
$587M
– –
-37,400
Closed -$198K
EOLS icon
52
Evolus
EOLS
$587M
– –
-281,541
Closed -$1.49M
IMVT icon
53
Immunovant
IMVT
$8.51B
– –
-95,500
Closed -$2.33M
MODV
54
DELISTED
ModivCare
MODV
– –
-14,923
Closed -$1.18M
NEO icon
55
NeoGenomics
NEO
$2.32B
– –
-38,819
Closed -$1.2M
PCRX icon
56
Pacira BioSciences
PCRX
$1.03B
– –
-55,000
Closed -$2.89M
PSNL icon
57
Personalis
PSNL
$1.82B
– –
-188,750
Closed -$2.45M
UTHR icon
58
United Therapeutics
UTHR
$22.1B
– –
-15,000
Closed -$1.81M
VCEL icon
59
Vericel Corp
VCEL
$2.1B
– –
-209,897
Closed -$2.9M
XERS icon
60
Xeris Biopharma Holdings
XERS
$1.55B
– –
-419,469
Closed -$1.12M
ONEM
61
PUT
DELISTED
1Life Healthcare
ONEM
– –
-8,000
Closed -$291K
LHCG
62
DELISTED
LHC Group LLC
LHCG
– –
-4,509
Closed -$786K
TPTX
63
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-25,602
Closed -$1.65M
MGLN
64
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-5,200
Closed -$379K
ZGNX
65
PUT
DELISTED
Zogenix, Inc.
ZGNX
– –
-8,200
Closed -$221K
1 2
3

Similar funds

SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
CCWM
Correct Capital Wealth Management Clayton, Missouri $580M AUM 16.45% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
MFS
McNamara Financial Services Marshfield, Massachusetts $580M AUM 17.89% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $581M AUM 8.55% 1-Year Est. Return
PWM
Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return
CA
COFG Advisors Oak Brook, Illinois $579M AUM

Prosight Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prosight Management held 65 positions worth $210M, down 9.8% from $233M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Prosight Management's Q3 2020 filing shows 13 new, 16 increased, 18 reduced and 18 closed positions. Its largest new stake was Prothena Corp: 545,195 shares worth $5.45M. The largest sale was Kura Oncology, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 82% a quarter earlier, followed by Technology and Miscellaneous.

  • Prosight Management's largest Q3 2020 buy was Prothena Corp: 545,195 shares worth $5.45M.
  • Prosight Management added most to Cue Biopharma in Q3 2020, an estimated $7.68M increase.
  • Prosight Management's biggest Q3 2020 reduction was Kura Oncology, cutting an estimated $12.8M.
  • Prosight Management fully exited Arrowhead Research in Q3 2020, selling an estimated $4.93M.
  • Prosight Management's ten largest holdings make up 49% of its $210M portfolio in Q3 2020.
  • Prosight Management opened 13 new positions and closed 18 in Q3 2020.
  • Prosight Management's portfolio value fell 9.8% quarter-over-quarter to $210M.

Based on Prosight Management's 13F filing for Q3 2020, filed 13 Nov 2020.